// App-Quantinova.ai

: CHARACTERISTICS OF PATIENTS RECEIVING EXTENDED TREATMENT AFTER INCIDENT VENOUS THROMBOEMBOLISM

Researchers

Presenter

  • Ida Ehlers Albertsen

Principal Investigators

  • Martin Jensen

  • Sebastian Kloss

  • Mette Sø gaard

  • Torben Bjerregaard Larsen

  • Peter Brønnum Nielsen

Medical Centers

  • Department of Rheumatology, Aalborg, Denmark

  • Aalborg Thrombosis Research Uni, Aalborg University, Aalborg, Denmark

Locations

  • Denmark

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

  • apixaban

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved